Implantica Advances RefluxStop Toward FDA Approval
ZUG, Switzerland, May 20, 2026 Implantica AG announced that it has submitted its final response to the U.S. Food...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ZUG, Switzerland, May 20, 2026 Implantica AG announced that it has submitted its final response to the U.S. Food...
AMSTERDAM, Netherlands, May 18, 2026 Royal Philips has introduced SmartIQ, a breakthrough AI-enabled coronary imaging technology developed for its...
